Benefits of photopheresis in the treatment of heart transplant patients with multiple/refractory rejection.
Dall'Amico
R
R
Department of Pediatrics, University of Padua, Italy.
Montini
G
G
Murer
L
L
Andreetta
B
B
Tursi
V
V
Feltrin
G
G
Guzzi
G
G
Angelini
A
A
Zacchello
G
G
Livi
U
U
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001707:Biopsy, Needle; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000473:pathology / Q000628:therapy*; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D017893:Photopheresis; D012008:Recurrence; D013997:Time Factors
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D008775:Methylprednisolone; D008727:Methotrexate